Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Myeloma Steering Committee

The NCI Myeloma Steering Committee (MYSC) was established in 2009.  At monthly meetings, it addresses the design, prioritization, and evaluation of concepts for phase II and phase III clinical trials in adult myeloma. View the MYSC member roster as of November 04, 2024.

Clinical Trial Planning Meetings (CTPMs)

CTPMs are held periodically and focus on specific clinical trial related topics. The following are important MYSC CTPMs:

  • Strategies and Planning Working Group
    In May 2011, the MYSC convened a meeting to develop a working definition for high risk myeloma and share ideas for clinical trials, translational studies, and accrual issues for myeloma patients. Read the executive summary.

Contact

For more information, contact NCI CCCT Program Director, Elena Schwartz, Ph.D. at elena.schwartz@nih.gov.

Email